New committee addresses private healthcare costs
The committee will include representatives from both ministries and Bank Negara Malaysia supported by a consultative council comprising key stakeholders in the private healthcare ecosystem.
'These representatives will include those from private hospitals, healthcare professionals, insurance and Takaful providers, consumer advocacy groups, and academia.
'The council will provide a dedicated platform for industry players to work together and contribute their expertise towards our shared goal of ensuring affordable and accessible private healthcare for all Malaysians,' both ministries said in a joint press statement on Tuesday (June 24).
Co-chaired by Finance Minister II Datuk Seri Amir Hamzah Azizan and Health Minister Datuk Seri Dr Dzulkefly Ahmad, the committee will plan and implement solutions to provide better healthcare value.
This will include building on previous initiatives, such as implementing co-payment requirements by Bank Negara and interim measures to reduce the impact of medical premium adjustments for policyholders from 2024 to 2026.
The committee will also work on Bank Negara's health financing initiative to reduce medical inflation, the Reset framework, focusing on five strategic thrusts, starting with restructuring medical and health insurance/Takaful (MHIT).
This will include increasing price transparency, strengthening the digital health ecosystem, expanding cost-effective care options, and reforming provider payment systems.
'The framework reflects a holistic commitment to implement solutions such as value-based care, prioritising health outcomes.
'Such initiatives will deliver tangible benefits to all Malaysians by easing congestion and overcrowding in public hospitals and clinics,' Dzulkefly said in the joint press statement.
Having held its first committee meeting on Tuesday, the ministries said key initiatives were already underway under Reset, featuring the development of basic MHIT products that balance affordability and sustainability.
Work is also being done on developing a diagnosis-related group (DRG)-based payment system for phased implementation and enhancing price transparency.
'This joint committee reflects our commitment to collaborate with all stakeholders in shaping a sustainable, transparent, and truly value-driven private healthcare system.
'Ultimately, this is about protecting the well-being of Malaysians and strengthening our nation's resilience,' Amir Hamzah said in the joint press statement.
Malaysia's current medical inflation rate stands at a noticeably high 15%, compared with the regional average of 11%, according to data from Aon International Insurance Brokers, as mentioned by Bank Negara governor Datuk Seri Abdul Rasheed Ghaffour on June 18.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Sun
17 hours ago
- The Sun
Cabinet addresses ATS drug abuse among youth in Malaysia
KOTA BHARU: The growing issue of Amphetamine Type Stimulants (ATS) addiction among young Malaysians has reached the Cabinet level, according to Youth and Sports Minister Hannah Yeoh. She revealed that the government is working with the Malaysian Communications and Multimedia Commission (MCMC) to tackle online drug sales, which are increasingly targeting minors. 'The current trend shows primary school pupils are getting involved with ATS. Some access it through online platforms like WhatsApp,' Yeoh told Bernama after visiting the Kota Bharu Narcotics Addiction Rehabilitation Centre (PUSPEN). She urged parents to monitor their children's smartphone use closely, stressing the need for supervision. Yeoh emphasised the ministry's commitment to helping young drug users seek voluntary treatment at PUSPEN. Parents noticing behavioural changes in their children were advised to contact the centre immediately. National Anti-Drug Agency (AADK) data for 2024 revealed 117,000 individuals aged 15 to 39 were involved in drug abuse, with Kelantan recording the highest addiction rates. Yeoh shared insights from her discussions with PUSPEN clients, some as young as 17, who began using drugs in primary school. 'While the trend is alarming, PUSPEN's 79% rehabilitation success rate is encouraging. The real challenge is preventing relapses by keeping recovered individuals away from old networks,' she said. Yeoh also met parents, urging early intervention and openness to seeking help. The ministry collaborates with AADK on awareness campaigns, including video screenings in cinemas like TGV. 'Young people must know they're not alone—support is available,' she added.
The Sun
a day ago
- The Sun
Top TV Anchors Lead National Stem Cell Awareness Drive
FOUR of Malaysia's most beloved TV news anchors — Gan Jiang Han, Lim She Ting, Tan Ley Teng, and Marsila Hassan — have stepped forward as the first YAKIN AMBASSADORS in a groundbreaking national initiative to demystify and democratise regenerative medicine. Launched by Yakin Splendour Global Holdings Bhd, the strategic brand arm of Yakin Medic Sdn Bhd, the campaign titled 'YAKIN Stem Cell Technology • Now Within Your Reach' is set to reshape how Malaysians understand and access stem cell therapy. At its heart, YAKIN AMBASSADORS is about building trust, sparking meaningful conversations, and showing that regenerative therapy is not only real — it's reachable. 'The vision behind YAKIN AMBASSADORS is to bridge the gap between science and society. 'This initiative is not just about public engagement — it's about sparking meaningful conversations, reducing misconceptions, and inspiring individuals to take control of their health through innovative and proven medical solutions,' said Patrick Tan, founder and chief executive officer of Yakin Group of Companies. Witnessed by Deputy Minister of Science, Technology and Innovation Datuk Mohammad Yusof Apdal, the signing ceremony signaled a pivotal moment for Malaysian healthcare, merging innovation with relatable advocacy. 'This initiative not only offers renewed hope to patients battling chronic and degenerative illnesses but also elevates Malaysia's standing in the field of medical tourism. 'I am proud to see local companies like Yakin Splendour actively transforming the nation's healthcare landscape, in line with the aspirations of the 12th Malaysia Plan and the national science, technology, and innovation agenda,,' said Yusof. A Personal and National Mission Founded in 2014, Yakin Medic has grown from a clinical data unit into one of Malaysia's foremost regenerative and stem cell therapy providers. Today, it offers hope to patients suffering from chronic diseases, age-related conditions, and degenerative illnesses. For Tan, the mission is deeply personal. After surviving third-degree burns in an accident, the very therapies he once advocated became vital to his recovery. 'I believed in the science, but I never imagined I'd become a patient myself. 'That experience changed everything. It became personal. 'Through further research, we found stem cells offered powerful solutions to these widespread health issues. It's one thing to believe in the science. It's another to be saved by it,' Tan explained. In September 2024, Yakin Medic entered into a technical collaboration with China-based IASO Biotherapeutics, combining CAR-T cell technology with regenerative therapies and iTeraCare resonant technology — a strategic move to position Malaysia as a regional biotech leader. Industry Partnerships and Expansion Adding momentum to the campaign, SceneFis Aesthetic, a prominent beauty centre and distributor for Yakin Splendour, has committed over RM400,000 in a strategic alliance. The partnership supports wellness, rejuvenation, and skin health — illustrating the vast potential of stem cell applications in both healthcare and aesthetics. 'We are proud to collaborate with Yakin Group. 'We believe these innovations can benefit many Malaysians seeking wellness and rejuvenation,' said Vesley Lee Siew Khim, Managing Director of SceneFis Aesthetic. A Vision for the Future Yakin Splendour is working to reduce the cost of stem cell therapy through bioreactor-based mass production, aiming to make treatments more affordable in the next two years. But safety and scientific integrity remain top priorities. 'This is a field that can't be rushed. Safety, science, and standards must always come first. 'Real science takes patience. Clinical trials, global standards, consistent quality and all of that matter because lives are at stake,' said Tan. Over the coming months, the YAKIN AMBASSADORS will participate in outreach programmes, community events, and storytelling initiatives that humanize stem cell therapy and offer real-world insight into its benefits. 'This is not just a campaign. It's a movement that uplifts, educates, and connects. 'It's about showing Malaysians that this isn't some distant or elitist science — it's something real, and it's here,' said Datuk Steven Lai, Director of Yakin Splendour Global Holdings Bhd.
The Sun
a day ago
- The Sun
Yakin Splendour launches YAKIN AMBASSADORS to bring stem cell therapy into the public sphere
FOUR of Malaysia's most beloved TV news anchors — Gan Jiang Han, Lim She Ting, Tan Ley Teng, and Marsila Hassan — have stepped forward as the first YAKIN AMBASSADORS in a groundbreaking national initiative to demystify and democratise regenerative medicine. Launched by Yakin Splendour Global Holdings Bhd, the strategic brand arm of Yakin Medic Sdn Bhd, the campaign titled 'YAKIN Stem Cell Technology • Now Within Your Reach' is set to reshape how Malaysians understand and access stem cell therapy. At its heart, YAKIN AMBASSADORS is about building trust, sparking meaningful conversations, and showing that regenerative therapy is not only real — it's reachable. 'The vision behind YAKIN AMBASSADORS is to bridge the gap between science and society. 'This initiative is not just about public engagement — it's about sparking meaningful conversations, reducing misconceptions, and inspiring individuals to take control of their health through innovative and proven medical solutions,' said Patrick Tan, founder and chief executive officer of Yakin Group of Companies. Witnessed by Deputy Minister of Science, Technology and Innovation Datuk Mohammad Yusof Apdal, the signing ceremony signaled a pivotal moment for Malaysian healthcare, merging innovation with relatable advocacy. 'This initiative not only offers renewed hope to patients battling chronic and degenerative illnesses but also elevates Malaysia's standing in the field of medical tourism. 'I am proud to see local companies like Yakin Splendour actively transforming the nation's healthcare landscape, in line with the aspirations of the 12th Malaysia Plan and the national science, technology, and innovation agenda,,' said Yusof. A Personal and National Mission Founded in 2014, Yakin Medic has grown from a clinical data unit into one of Malaysia's foremost regenerative and stem cell therapy providers. Today, it offers hope to patients suffering from chronic diseases, age-related conditions, and degenerative illnesses. For Tan, the mission is deeply personal. After surviving third-degree burns in an accident, the very therapies he once advocated became vital to his recovery. 'I believed in the science, but I never imagined I'd become a patient myself. 'That experience changed everything. It became personal. 'Through further research, we found stem cells offered powerful solutions to these widespread health issues. It's one thing to believe in the science. It's another to be saved by it,' Tan explained. In September 2024, Yakin Medic entered into a technical collaboration with China-based IASO Biotherapeutics, combining CAR-T cell technology with regenerative therapies and iTeraCare resonant technology — a strategic move to position Malaysia as a regional biotech leader. Industry Partnerships and Expansion Adding momentum to the campaign, SceneFis Aesthetic, a prominent beauty centre and distributor for Yakin Splendour, has committed over RM400,000 in a strategic alliance. The partnership supports wellness, rejuvenation, and skin health — illustrating the vast potential of stem cell applications in both healthcare and aesthetics. 'We are proud to collaborate with Yakin Group. 'We believe these innovations can benefit many Malaysians seeking wellness and rejuvenation,' said Vesley Lee Siew Khim, Managing Director of SceneFis Aesthetic. A Vision for the Future Yakin Splendour is working to reduce the cost of stem cell therapy through bioreactor-based mass production, aiming to make treatments more affordable in the next two years. But safety and scientific integrity remain top priorities. 'This is a field that can't be rushed. Safety, science, and standards must always come first. 'Real science takes patience. Clinical trials, global standards, consistent quality and all of that matter because lives are at stake,' said Tan. Over the coming months, the YAKIN AMBASSADORS will participate in outreach programmes, community events, and storytelling initiatives that humanize stem cell therapy and offer real-world insight into its benefits. 'This is not just a campaign. It's a movement that uplifts, educates, and connects. 'It's about showing Malaysians that this isn't some distant or elitist science — it's something real, and it's here,' said Datuk Steven Lai, Director of Yakin Splendour Global Holdings Bhd.
